Literature DB >> 15907642

Molecular biology of opioid analgesia.

Gavril W Pasternak1.   

Abstract

Opioids provide excellent pain relief in most patients. Yet the responses of patients to individual opioids can vary markedly, even among the mu opioids. Understanding this variability would greatly enhance our ability to treat patients appropriately. Classical pharmacological studies have long implied the existence of multiple subtypes of mu opioid receptors. More recently, a number of variants of the cloned mu opioid receptor have been described. These variants all show the same selectivity for mu opioids, confirming their classification as mu opioid receptors. Yet, they differ in their functional activation by opioids as well as in their localization within cells and regions in the brain. These multiple mu opioid receptors may help explain the range of responses seen clinically among patients for the various opioid drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907642     DOI: 10.1016/j.jpainsymman.2005.01.011

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  35 in total

Review 1.  The pharmacological basis of opioids.

Authors:  Carla Ghelardini; Lorenzo Di Cesare Mannelli; Enrica Bianchi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

2.  75 years of opioid research: the exciting but vain quest for the Holy Grail.

Authors:  Alistair D Corbett; Graeme Henderson; Alexander T McKnight; Stewart J Paterson
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 3.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 4.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

5.  Effect of implementing pain management standards.

Authors:  Smitha Narasimhaswamy; Charanjit Vedi; Ylone Xavier; Chi-hong Tseng; Daniel Shine
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

Review 6.  Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.

Authors:  Spencer Dorn; Anthony Lembo; Filippo Cremonini
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

7.  Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: Differences by insurance status.

Authors:  Vítor Soares Tardelli; Thiago Marques Fidalgo; Julian Santaella; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2019-09-21       Impact factor: 4.492

Review 8.  β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.

Authors:  Kirsten M Raehal; Laura M Bohn
Journal:  Handb Exp Pharmacol       Date:  2014

9.  Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.

Authors:  Jillian L Scavone; Ken Mackie; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2009-11-18       Impact factor: 3.252

10.  Challenges in using opioids to treat pain in persons with substance use disorders.

Authors:  Seddon R Savage; Kenneth L Kirsh; Steven D Passik
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.